Efficacy and Safety of Hospital-Based Intravenous Immunoglobulin and Home-Based Self-Administered Subcutaneous Immunoglobulin in Polish Children with Primary Immunodeficiency Diseases

被引：0
|
作者：
Katarzyna Bal
Izabela Kałuzińska-Parzyszek
Agnieszka Sobocińska
Daniela Podlecka
Joanna Jerzyńska
Iwona Stelmach
机构：
[1] Copernicus Memorial Hospital,Department of Pediatrics and Allergy, Medical University of Lodz
来源：
The Indian Journal of Pediatrics | 2015年 / 82卷
关键词：
Respiratory Tract Infection; Primary Immunodeficiency; Systemic Adverse Event; IVIG Therapy; Primary Immunodeficiency Disease;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：768 / 769
页数：1
相关论文
共 47 条
  • [31] Tolerability profile of high-dose 10% liquid intravenous immunoglobulin in myasthenia gravis administered in a home-based setting
    Rigas, M.
    Sterling, R.
    JOURNAL OF NEUROLOGY, 2008, 255 : 183 - 183
  • [32] Efficacy and Safety of IgPro20, a 20% Immunoglobulin for Subcutaneous Administration, in Patients with Primary Immunodeficiency Switching from Intravenous Replacement Therapy
    Jolles, Stephen
    Cristea, Victor
    Wahn, Volker
    Debre, Marianne
    Longhurst, Hilary
    Zenker, Othmar
    Peter, Hans-Hartmut
    Borte, Michael
    CLINICAL IMMUNOLOGY, 2010, 135 : S86 - S87
  • [33] Efficacy and Safety of IgPro20, a Subcutaneous Immunoglobulin, in Japanese Patients with Primary Immunodeficiency Diseases (vol 6, pg 169, 2013)
    Kanegane, Hirokazu
    Imai, Kohsuke
    Yamada, Masafumi
    Takada, Hidetoshi
    Ariga, Tadashi
    Bexon, Martin
    Rojavin, Mikhail
    Hu, Wilson
    Kobayashi, Midori
    Lawo, John-Philip
    Nonoyama, Shigeaki
    Hara, Toshiro
    Miyawaki, Toshio
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (04) : 520 - 520
  • [34] Tolerability profile of high-dose 10% liquid intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy administered in a home-based setting
    Rigas, M.
    Sterling, R.
    JOURNAL OF NEUROLOGY, 2008, 255 : 124 - 124
  • [35] SWITCHING PATIENTS WITH PRIMARY ANTIBODY DEFICIENCIES TO HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN: ECONOMIC EVALUATION OF AN INTERPROFESSIONAL DRUG THERAPY MANAGEMENT PROGRAM
    Perraudin, C.
    Bourdin, A.
    Berger, J.
    Bugnon, O.
    VALUE IN HEALTH, 2014, 17 (07) : A424 - A424
  • [36] Home-based subcutaneous immunoglobulin G replacement therapy under real-life conditions in children and adults with antibody deficiency
    F Hoffmann
    B Grimbacher
    J Thiel
    HH Peter
    BH Belohradsky
    European Journal of Medical Research, 15 (6)
  • [37] HOME-BASED SUBCUTANEOUS IMMUNOGLOBULIN G REPLACEMENT THERAPY UNDER REAL-LIFE CONDITIONS IN CHILDREN AND ADULTS WITH ANTIBODY DEFICIENCY
    Hoffmann, F.
    Grimbacher, B.
    Thiel, J.
    Peter, H. -H.
    Belohradsky, B. H.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2010, 15 (06) : 238 - 245
  • [38] Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases
    Patel, Niraj C.
    Walter, Jolan E.
    Wasserman, Richard L.
    Rubinstein, Arye
    Kankirawatana, Suthida
    Shepherd, Meagan W.
    Greco, Erin
    Li, Zhaoyang
    Russo-Schwarzbaum, Sharon
    Saeed-Khawaja, Shumyla
    Mccoy, Barbara
    Yel, Leman
    JOURNAL OF CLINICAL IMMUNOLOGY, 2025, 45 (01)
  • [39] Efficacy, safety and pharmacokinetics of a new 10% normal human immunoglobulin for intravenous infusion, BT595, in children and adults with primary immunodeficiency disease
    Krivan, Gergely
    Borte, Michael
    Harris, James B.
    Lumry, William R.
    Aigner, Silke
    Lentze, Stephan
    Staiger, Christiane
    VOX SANGUINIS, 2022, 117 (10) : 1153 - 1162
  • [40] Efficacy and Safety of PlasmaCap IG, A New 10% Intravenous Immunoglobulin Manufactured Using an Innovative Chromatography Process, in Adults and Children with Primary Immunodeficiency Disorders
    Wasserman, Richard
    Leiding, Jennifer
    Lumry, William
    Scarupa, Mark
    Suez, Daniel
    Gupta, Sudhir
    Routes, John
    Zecca, Tina
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S66 - S66
12345